Research report
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients

https://doi.org/10.1016/j.jad.2009.02.028Get rights and content

Abstract

Introduction

We hypothesized that predominant episode-polarity would predict response to treatment of depressive episodes in bipolar I disorder (BPD) patients with treatment in a placebo-controlled trial, in the sense that patients with manic predominant polarity (PM) would respond better than patients with depressive predominant polarity (PD).

Method

This post-hoc analysis of a published trial examined outcomes of 788 depressed (MADRS score ≥ 20) adult BPD patients with baseline and follow-up assessments, according to their predominant polarity based on previous recurrences of mania-hypomania vs. depression in ≥ 2:1 excess. Patients (total = 833) were randomized to an 8-week trial of treatment with placebo (n = 377), olanzapine (5–20 mg/day; n = 370), or olanzapine/fluoxetine combination (OFC; 6/25, 6/50, or 12/50 mg/day; n = 86). Treatment response was based on improvement in Clinical Global Impression of depression severity (CGI-D). We analyzed for associations of this outcome with predominant lifetime illness-polarity, based on retrospective SCID-based assessment of individual clinical history.

Results

Predominant polarity could be demonstrated in 367/788 patients (46.6%), showing a 2.7-fold excess of predominant depressive over manic past-illnesses (34.1%/12.4%), with similar distribution by sex and among treatment-arms. Moreover, based on least-square change in CGI-D severity (based on a mixed model of repeated measures [MMRM]), predominant polarity has different impact in the treatment outcome for each gender. Men with predominantly manic polarity had statistically significant better improvement than men with predominantly depressive polarity. Such difference was not observed in the female population. Other outcome measures yielded similar conclusions.

Conclusions

Predominant previous depressive > manic episodes selectively yielded poorer responses of BPD to treatment for acute BP depression, particularly in men.

Section snippets

Subjects

Study subjects were adults (≥ 18 years) who met DSM-IV-TR (American Psychiatric Association (APA), 2000) criteria for type I BPD, and a current episode of major depression. For the original RCT (Tohen et al., 2003), a total of 833/1072 patients were recruited from inpatient and outpatient services from 84 study sites in 13 countries from June 2000 through December 2001. Diagnosis was confirmed by the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders,

Subject characteristics

Of the 833 subjects enrolled in the trial, 788 subjects had both baseline and follow-up ratings so as to allow outcome assessments; of these patients, 367/788 (46.6%) could be categorized as having had predominantly depressive (PD; 269/788; 34.1%) or predominantly manic polarity (PM; 98/788; 12.4%) whereas 53.4% had uncertain polarity (PU; 421/788). That is, somewhat less than half of type I BPD patients could be categorized by predominant episode polarity, and the PD pattern was 2.74-times

Discussion

To our knowledge this is the first attempt to analyze for potential effects of predominant past episode polarities in type-I BPD patients in a placebo-controlled RCT, in this instance, we used a trial of olanzapine or olanzapine/fluoxetine in BP major depression involving 833 patients, of whom 788 had baseline and follow-up assessments and 367 (46.6%) could be characterized by past history as PM or PD (18), or somewhat less than two previous experiences with the successful categorization of

Conclusions

Predominant polarity proved to be useful in predicting short-term outcome of depressive episodes, albeit only among men with BPD. A predominance of depressive recurrences was more common than manic recurrences among both men and women diagnosed with BPD, as expected from previous studies finding a great excess of depressive illness in treated BPD patients followed over time. An excess of depressive illness proved to be a useful predictor of inferior responses in acute depressive episodes, but

Role of funding source

Study funded by Lilly.

Conflict of interest

Dr. Vieta has received grants from Instituto Carlos III, CIBER-SAM, Spain, and has also received grants unrelated to this study and has acted as consultant for the following companies: Astra-Zeneca, Bristol-Myers-Squibb, Eli Lilly, Glaxo-Smith-Kline, Janssen-Cilag, Merck Sharp & Dohme, Novartis, Organon, Otsuka, Pfizer, Sanofi, and Servier. Dr. Berk has received Grant/Research Support from the Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation,

Acknowledgements

This study was supported by Eli Lilly and was based on data provided from Eli Lilly — supported randomized, controlled trials (to EV, MB and FC), and by a grant from the Ministerio de Educación y Ciencia, Madrid, Spain (to EV) and by Bruce J. Anderson Foundation and the McLean Private Donors' Research Fund (to RJB).

References (33)

  • BaldessariniR.J. et al.

    Bipolar disorder

  • ColomF. et al.

    The road to DSM-V: bipolar disorder episode and course specifiers

    Psychopathology

    (2009)
  • FaeddaG.L. et al.

    Episode sequence in bipolar disorder and response to lithium treatment

    Am. J. Psychiatry

    (1991)
  • FirstM.B. et al.

    Structured Clinical Interview for DSM-IV® Axis II Personality Disorders (SCID-II)

    (1997)
  • FirstM.B. et al.

    Structured Clinical Interview for DSM-IV® Axis I Disorders (SCID-I)

    (1997)
  • GhaemiS.N. et al.

    Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report

    Bipolar Disord.

    (2008)
  • Cited by (58)

    • The biological basis of predominant polarity

      2020, Neurobiology of Bipolar Disorder: Road to Novel Therapeutics
    • Predominant polarity in bipolar disorder patients: The COPE bipolar sample

      2019, Journal of Affective Disorders
      Citation Excerpt :

      The most recent and only review in the field by Carvalho et al. (2014) indicated differences between the two predominant polarities. A sample of exclusively type I BD patients showed more MPP (Vieta et al., 2009; Popovic et al., 2013); this pattern was reversed for samples of exclusively type II BD patients (Rosa et al., 2008; Vieta et al., 2009; Judd et al., 2003; Popovic et al., 2013). Studies have suggested that DPP was more closely associated with socio-demographic features such as being a woman (Popovic et al., 2014; Baldessarini et al., 2012) and being married (Baldessarini et al., 2012; Gonzalez-Pinto et al., 2010; Nivoli et al., 2014).

    View all citing articles on Scopus
    View full text